Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday ...

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

U.S. senators questioned Novo Nordisk CEO Lars Fruergaard Jørgensen about the high costs of the company's GLP-1 drugs, which include popular weight-loss drugs Wegovy and Ozempic. It comes after North ...

Novo Nordisk CEO commits to exploring ways to make weight-loss drugs more affordable for U.S. patients after hearing from ...

Our editors also may be in touch with follow-up questions. Due to a Wegovy shortage coupled with Ozempic’s weight loss effects going viral on social media, people without type 2 diabetes have ...

Earlier today, Novo Nordisk announced that its weight-loss drug liraglutide is safe ... with side effects in line with those of Ozempic and Wegovy. Most adverse events reported were mild to ...

As your White House correspondent, I ask the tough questions and seek the answers that matter. Your support enables me to be in the room, pressing for transparency ...

Its use there has soared, as it has almost everywhere. Weight-loss drugs like Ozempic and Wegovy seemed to work magic when they were launched and are quickly being joined by other drugs that work ...

Released in 2017 and 2021, Ozempic and Wegovy, generically known as semaglutide, promised significant weight loss and have been effective in treating chronic conditions. However, long-term side ...

Weight loss shots like Ozempic and Wegovy have been linked to 162 deaths in the United States over the past six years, according to the Daily Mail. These casualties are listed in the FDA’s FAERS ...

It has been eight years since weight-loss drug Ozempic hit the market, while Wegovy surfaced in 2021. Since then many reports have been written about the wider health benefits of the so called ...